Please assess the completion status of the following clinical trial:

Trial Title: Autologous Blood for Full-thickness Macular Hole

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Primary and recurrent holes~Exclusion Criteria:~* Lamellar and pseudoholes

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Utilizing autologous whole blood for the full thickness macular hole (Type: EXPERIMENTAL): It is an interventional study by performing pars-plana vitrectomy

Based on this trial design, predict the completion outcome and termination type (if applicable).